Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 3 | Reproductive Biology and Endocrinology

Figure 3

From: International regulatory landscape and integration of corrective genome editing into in vitro fertilization

Figure 3

An international regulatory landscape regarding human germline gene modification. Thirty nine countries were surveyed and categorized as “Ban based on legislation” (25, pink), “Ban based on guidelines” (4, faint pink), “Ambiguous” (9, gray), and “Restrictive” (1, light gray). Non-colored countries were excluded in this survey. See also Additional file 1: Table S1.

Back to article page